Piperazine- and piperidine-derivatives as melanocortin receptor agonists
US7186715B2 · kind B2 · utility
3Cited by
1References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 23, 2002 |
| Grant date | Mar 6, 2007 |
| Priority date | — |
| Expiry date | Dec 4, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to melanocortin receptor agonists of formula I, which is useful in the treatment of obesity, diabetes and male and/or female sexual dysfunction
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.